TrialDrug design, development and therapy2013

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma.

Hongqing Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.